Cardio Diagnostics Holdings Inc
CDIO4.000USD
+0.120+3.09%
Cierre 08/04, 16:00（ET）Cotizaciones retrasadas 15 min
231.82KCap. mercado
PérdidaP/E TTM
Más Datos de Cardio Diagnostics Holdings Inc Compañía
Cardio Diagnostics Holdings, Inc. is an artificial intelligence-powered precision cardiovascular medicine company. The Company develops and commercializes a series of products for various types of cardiovascular disease and associated co-morbidities, including coronary heart disease (CHD), stroke, heart failure and diabetes, by leveraging its artificial intelligence (AI)-driven Integrated Genetic-Epigenetic Engine. Its first product, Epi+Gen CHD, is an epigenetics-based clinical blood test capable of assessing near-term (three-year) risk for CHD, and its second product, PrecisionCHD, is an epigenetics-based clinical blood test for the detection of CHD. CardioInnovate360 is a research use only (RUO) solution to support the discovery, development and validation of biopharmaceuticals for the assessment and management of cardiovascular diseases. HeartRisk is a cardiovascular risk intelligence platform that combines insights from anonymized and aggregated clinical cardiovascular data.
Información de la empresa
Símbolo de cotizaciónCDIO
Nombre de la empresaCardio Diagnostics Holdings Inc
Fecha de salida a bolsaNov 23, 2021
Director ejecutivoDr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Número de empleados13
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 23
Dirección311 W. Superior Street
CiudadCHICAGO
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal60645
Teléfono18552269991
Sitio Web
Símbolo de cotizaciónCDIO
Fecha de salida a bolsaNov 23, 2021
Director ejecutivoDr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Timur Dogan, Ph.D.
Mr. Timur Dogan, Ph.D.
Chief Technology Officer
Chief Technology Officer
4.28K
-34.96%
Dr. Warren Hosseinion, M.D.
Dr. Warren Hosseinion, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
3.87K
--
Dr. Robert Philibert, M.D., Ph.D.
Dr. Robert Philibert, M.D., Ph.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
3.25K
--
Mr. James Intrater
Mr. James Intrater
Independent Director
Independent Director
2.39K
--
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Elisa Luqman, Esq., J.D.
Ms. Elisa Luqman, Esq., J.D.
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Paul Burton, J.D.
Mr. Paul Burton, J.D.
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Timur Dogan, Ph.D.
Mr. Timur Dogan, Ph.D.
Chief Technology Officer
Chief Technology Officer
4.28K
-34.96%
Dr. Warren Hosseinion, M.D.
Dr. Warren Hosseinion, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
3.87K
--
Dr. Robert Philibert, M.D., Ph.D.
Dr. Robert Philibert, M.D., Ph.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
3.25K
--
Mr. James Intrater
Mr. James Intrater
Independent Director
Independent Director
2.39K
--
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Elisa Luqman, Esq., J.D.
Ms. Elisa Luqman, Esq., J.D.
Chief Financial Officer
Chief Financial Officer
--
--
Desglose de ingresos
Sin datos
Sin datos
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: sáb., 17 de may
Actualizado: sáb., 17 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Dogan (Meeshanthini)
3.17%
Bd Holding, Inc
3.04%
BlackRock Institutional Trust Company, N.A.
2.05%
Geode Capital Management, L.L.C.
0.76%
The Vanguard Group, Inc.
0.71%
Other
90.27%
Accionistas
Accionistas
Proporción
Dogan (Meeshanthini)
3.17%
Bd Holding, Inc
3.04%
BlackRock Institutional Trust Company, N.A.
2.05%
Geode Capital Management, L.L.C.
0.76%
The Vanguard Group, Inc.
0.71%
Other
90.27%
Tipos de accionistas
Accionistas
Proporción
Individual Investor
4.21%
Investment Advisor
3.47%
Corporation
3.04%
Investment Advisor/Hedge Fund
0.97%
Research Firm
0.16%
Hedge Fund
0.12%
Venture Capital
0.11%
Other
87.91%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
44
210.25K
12.09%
-12.08K
2025Q1
46
215.87K
12.62%
-11.61K
2024Q4
51
6.58M
12.62%
+556.91K
2024Q3
70
5.72M
21.51%
-4.06M
2024Q2
76
5.70M
26.20%
-6.56M
2024Q1
73
5.54M
28.62%
-6.62M
2023Q4
73
5.55M
28.89%
-5.24M
2023Q3
68
4.28M
41.11%
-6.26M
2023Q2
64
4.02M
40.37%
-6.37M
2023Q1
59
3.90M
40.53%
-6.83M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Dogan (Meeshanthini)
55.18K
3.17%
--
--
Mar 20, 2025
Bd Holding, Inc
52.88K
3.04%
--
--
Mar 20, 2025
BlackRock Institutional Trust Company, N.A.
35.57K
2.05%
--
--
Mar 31, 2025
Geode Capital Management, L.L.C.
13.17K
0.76%
+1.02K
+8.41%
Mar 31, 2025
The Vanguard Group, Inc.
12.42K
0.71%
+4.68K
+60.47%
Mar 31, 2025
UBS Financial Services, Inc.
5.57K
0.32%
+3.35K
+150.95%
Mar 31, 2025
Dogan (Timur)
4.28K
0.25%
-2.30K
-34.96%
Mar 20, 2025
Hosseinion (Warren)
3.87K
0.22%
--
--
Mar 20, 2025
Philibert (Robert)
3.25K
0.19%
--
--
Mar 20, 2025
Jane Street Capital, L.L.C.
2.69K
0.15%
-1.06K
-28.20%
Mar 31, 2025
Ver más
ETFs relacionados
Nombre
Proporción
Sin datos
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
